Premium
Clinical predictors of COVID ‐19 severity and bleeding in the ACTIV‐4B COVID ‐19 outpatient thrombosis prevention trial
Author(s) -
Connors Jean M.,
Brooks Maria M.,
Sciurba Frank C.,
Fu Zhuxuan,
Ridker Paul M.
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26553
Subject(s) - medicine , apixaban , pulmonary embolism , clinical endpoint , randomized controlled trial , myocardial infarction , stroke (engine) , population , intention to treat analysis , antithrombotic , placebo , thrombosis , clinical trial , rivaroxaban , warfarin , atrial fibrillation , mechanical engineering , alternative medicine , environmental health , pathology , engineering
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom